Heart Test Laboratories Stock Performance
| HSCSW Stock | USD 0.03 0.00 0.00% |
Heart Test holds a performance score of 15 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -2.15, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Heart Test are expected to decrease by larger amounts. On the other hand, during market turmoil, Heart Test is expected to outperform it. Use Heart Test Laboratories information ratio, as well as the relationship between the value at risk and kurtosis , to analyze future returns on Heart Test Laboratories.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Heart Test Laboratories are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Heart Test showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.7 M |
Heart |
Heart Test Relative Risk vs. Return Landscape
If you would invest 3.51 in Heart Test Laboratories on August 26, 2024 and sell it today you would lose (0.50) from holding Heart Test Laboratories or give up 14.25% of portfolio value over 90 days. Heart Test Laboratories is currently producing 44.5354% returns and takes up 221.4063% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Heart, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Heart Test Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Heart Test's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Heart Test Laboratories, and traders can use it to determine the average amount a Heart Test's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2011
| Best Portfolio | Best Equity | HSCSW | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 221.41 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average Heart Test is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Heart Test by adding it to a well-diversified portfolio.
Heart Test Fundamentals Growth
Heart Stock prices reflect investors' perceptions of the future prospects and financial health of Heart Test, and Heart Test fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Heart Stock performance.
| Return On Equity | -2.69 | ||||
| Return On Asset | -0.82 | ||||
| Operating Margin | (379.07) % | ||||
| Revenue | 18.6 K | ||||
| EBITDA | (6.16 M) | ||||
| Net Income | (6.61 M) | ||||
| Cash And Equivalents | 723.48 K | ||||
| Cash Per Share | 0.22 X | ||||
| Total Debt | 1.04 M | ||||
| Current Ratio | 0.59 X | ||||
| Book Value Per Share | 6.55 X | ||||
| Cash Flow From Operations | (6.07 M) | ||||
| Earnings Per Share | (1.09) X | ||||
| Total Asset | 9.5 M | ||||
| Retained Earnings | (67.36 M) | ||||
| Working Capital | 5.6 M | ||||
About Heart Test Performance
Evaluating Heart Test's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Heart Test has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Heart Test has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 37.8 K | 30.3 K | |
| Return On Tangible Assets | (0.83) | (0.88) | |
| Return On Capital Employed | (0.81) | (0.85) | |
| Return On Assets | (0.70) | (0.73) | |
| Return On Equity | (0.90) | (0.95) |
Things to note about Heart Test Laboratories performance evaluation
Checking the ongoing alerts about Heart Test for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Heart Test Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Heart Test is not yet fully synchronised with the market data | |
| Heart Test is way too risky over 90 days horizon | |
| Heart Test has some characteristics of a very speculative penny stock | |
| Heart Test appears to be risky and price may revert if volatility continues | |
| Heart Test has high likelihood to experience some financial distress in the next 2 years | |
| Heart Test Laboratories has accumulated 1.04 M in total debt. Heart Test Laboratories has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Heart Test's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the revenue of 18.6 K. Net Loss for the year was (6.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Heart Test Laboratories has accumulated about 723.48 K in cash with (6.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Heart Test has a poor financial position based on the latest SEC disclosures |
- Analyzing Heart Test's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Heart Test's stock is overvalued or undervalued compared to its peers.
- Examining Heart Test's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Heart Test's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Heart Test's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Heart Test's stock. These opinions can provide insight into Heart Test's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.